Back to Browse Journals » Clinical Interventions in Aging » Volume 2 » Issue 4

Testosterone replacement therapy for older men

Authors Stephen E Borst, Thomas Mulligan

Published Date January 2007 Volume 2007:2(4) Pages 561—566

DOI http://dx.doi.org/10.2147/CIA.S1609

Published 3 January 2007

Stephen E Borst, Thomas Mulligan

Geriatrics Research, Education, and Clinical Center, North Florida/South Georgia Veterans Health System, Gainesville, FL, USA

Abstract: Despite intensive research on testosterone therapy for older men, important questions remain unanswered. The evidence clearly indicates that many older men display a partial androgen deficiency. In older men, low circulating testosterone is correlated with low muscle strength, with high adiposity, with insulin resistance and with poor cognitive performance. Testosterone replacement in older men has produced benefits, but not consistently so. The inconsistency may arise from differences in the dose and duration of testosterone treatment, as well as selection of the target population. Generally, studies reporting anabolic responses to testosterone have employed higher doses of testosterone for longer treatment periods and have targeted older men whose baseline circulating bioavailable testosterone levels were low. Most studies of testosterone replacement have reported anabolic that are modest compared to what can be achieved with resistance exercise training. However, several strategies currently under evaluation have the potential to produce greater anabolic effects and to do so in a safe manner. At this time, testosterone therapy can not be recommended for the general population of older men. Older men who are hypogonadal are at greater risk for the catabolic effects associated with a number of acute and chronic medical conditions. Future research is likely to reveal benefits of testosterone therapy for some of these special populations. Testosterone therapy produces a number of adverse effects, including worsening of sleep apnea, gynecomastia, polycythemia and elevation of PSA. Efficacy and adverse effects should be assessed frequently throughout the course of therapy.
Keywords: aging, testosterone, hypogonadism, physical function

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Femtosecond laser versus mechanical microkeratome-assisted flap creation for LASIK: a prospective, randomized, paired-eye study

Pajic B, Vastardis I, Pajic-Eggspuehler B, Gatzioufas Z, Hafezi F

Clinical Ophthalmology 2014, 8:1883-1889

Published Date: 22 September 2014

Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes

Cosco D, Federico C, Maiuolo J, Bulotta S, Molinaro R, Paolino D, Tassone P, Fresta M

International Journal of Nanomedicine 2014, 9:2359-2372

Published Date: 15 May 2014

The clinical usefulness of central hemodynamics to evaluate diastolic dysfunction in subjects without hypertension

Kim GH, Kim JH, Moon KW, Yoo KD, Ihm SH, Youn HJ, Kim CM

Clinical Interventions in Aging 2014, 9:527-533

Published Date: 28 March 2014

Effect of a steam foot spa on geriatric inpatients with cognitive impairment: a pilot study

Koike Y, Kondo H, Kondo S, Takagi M, Kano Y

Clinical Interventions in Aging 2013, 8:543-548

Published Date: 16 May 2013

Erratum

Sumi C, Ichimaru K, Shinozuka Y

Reports in Medical Imaging 2011, 4:67-68

Published Date: 25 November 2011

Thioperamide induces CD4+ CD25+ Foxp3+ regulatory T lymphocytes in the lung mucosa of allergic mice through its action on dendritic cells

Amaral MM, Alvarez CA, Langellotti C, Jancic C, Salamone G, Geffner J, Vermeulen M

Journal of Asthma and Allergy 2011, 4:93-102

Published Date: 26 September 2011

Corrigendum

Dove Medical Press Editorial

Clinical Interventions in Aging 2008, 3:397-397

Published Date: 30 June 2008

Marked effect of milnacipran combined with olanzapine for a delusional depressive patient

Yuka Sugawara, Hisashi Higuchi, Keizo Yoshida, Tetsuo Shimizu

Neuropsychiatric Disease and Treatment 2005, 1:373-374

Published Date: 18 February 2005

Lercanidipine in hypertension

Claudio Borghi

Vascular Health and Risk Management 2005, 1:173-182

Published Date: 29 January 2005